Merck's drug reduced bad cholesterol by up to 64.6% in late-stage trial
- Posted on March 30, 2026
- By Yahoo News
- 7 Views
Merck's drug reduced bad cholesterol by up to 64.6% in late-stage trial
March 30 () - Merck's oral drug reduced bad cholesterol by up to 64.6% in a late-stage trial, the drugmaker said on Monday, as it looks for its next blockbuster candidate.
